SCHEMBL468832

SCHEMBL468832

CC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.69
▸ ACE P12821 4/20 0.65
▸ POLB P06746 3/20 0.62
▸ P2RY14 Q15391 1/20 0.62
▸ TP53 P04637 1/20 0.62
▸ ITGB2 P05107 3/20 0.62
▸ ICAM1 P05362 3/20 0.62
▸ ITGAL P20701 3/20 0.62
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ MAPT P10636 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ HTT P42858 1/20 0.60
▸ ECE1 P42892 4/20 0.60
▸ ERAP2 Q6P179 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468831 1.00 ALOX15 (0.69) ALOX15ACEPOLBP2RY14TP53
SCHEMBL15702236 0.89 MMP9 (0.64) SMN1; SMN2
SCHEMBL16672124 0.89 ALOX15 (0.64) ALOX15ACEPOLBP2RY14TP53
Acetyltryptophan SCHEMBL29401158 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1
Acetyltryptophan SCHEMBL4216450 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1
Acetyltryptophan SCHEMBL57141 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1
Acetyltryptophan SCHEMBL4216452 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1
Acetyltryptophan SCHEMBL57140 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1
Acetyltryptophan SCHEMBL702442 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1
Acetyltryptophan SCHEMBL29360698 0.88 ALOX15 (0.79) ALOX15ACEPOLBITGB2ICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2311452-B2 Topical composition comprising n-acetyl glucosamine YU RUEY J (US) 2020-12-30 — — EP disclosed
EP-2311452-B9 Topical composition comprising n-acetyl glucosamine YU RUEY J (US) 2014-12-24 — — EP disclosed
US-RE44302-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use YU RUEY J (US) 2013-06-18 — — US disclosed
US-RE44017-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use YU RUEY J (US) 2013-02-19 — — US disclosed
US-RE42902-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use TRISTRATA, INC. (US) 2011-11-08 — — US disclosed
EP-2311452-A1 Topical composition comprising n-acetyl glucosamine Yu, Ruey J. (US) 2011-04-20 — — EP disclosed
US-RE41339-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use TRISTRATA, INC. (US) 2010-05-18 — — US disclosed
US-RE41278-E1 N-acetyl aldosamines and related N-acetyl compounds, and their topical use TRISTRATA, INC. 2010-04-27 — — US disclosed
EP-2080504-A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids Yu, Ruey J. (US) 2009-07-22 — — EP disclosed
EP-1639994-A2 Topical composition comprising N-acetylaldosamines or N-acetylamino acids Yu, Ruey J., Dr. (US) 2006-03-29 — — EP disclosed
EP-1570840-A2 TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS Yu, Ruey J., Dr. (US) 2005-09-07 — — EP disclosed
US-6524593-B1 Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails TRISTRATA, INC. 2003-02-25 — — US disclosed
EP-1143925-A1 TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS Yu, Ruey J., Dr. (US) 2001-10-17 — — EP disclosed
US-6159485-A COSMETICS; SKIN DISORDERS YUGENIC LIMITED PARTNERSHIP (US) 2000-12-12 — — US disclosed
WO-2000040217-A1 TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS YUGENIC LIMITED PARTNERSHIP (US) 2000-07-13 — — WO disclosed
Send feedback